Position in MRNA
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$108,314,083
+$55,557,920 QoQ
Shares Held
2,132,167
+19.2% QoQ
Ownership
0.537%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 76.11378470823345.ToString("F0")%
Shared 19.660795800704168.ToString("F0")%
None 4.22541949106238.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. MRNA ranks #11 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $108,314,083 | 2,132,167 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $52,756,163 | 1,788,951 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $20,706,333 | 801,639 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $30,610,192 | 1,109,467 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $43,404,699 | 1,531,030 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $69,408,951 | 1,669,287 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $122,033,850 | 1,826,034 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $169,491,873 | 1,427,300 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $148,942,533 | 1,397,734 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $129,997,457 | 1,307,164 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $189,848,360 | 1,838,013 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $269,428,192 | 2,217,516 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $393,157,732 | 2,559,954 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $421,921,809 | 2,348,969 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $248,981,403 | 2,105,551 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $179,737,009 | 1,258,222 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $170,102,960 | 987,478 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $238,670,847 | 939,723 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $240,322,363 | 624,441 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $67,412,942 | 286,888 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $37,466,235 | 286,111 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $35,158,751 | 336,544 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $18,573,077 | 262,517 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $15,753,024 | 245,336 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,427,327 | 47,657 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||